504413-35-8

Basic information

• Product Name: N-(6-BroMoiMidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetaMide
• Synonyms: N-(6-BroMoiMidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetaMide;AcetaMide, N-(6-broMoiMidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoro-
• CAS NO: 504413-35-8
• Molecular Formula: C₉H₅BrF₃N₃O
• Molecular Weight: 308.0547096
• Mol File: 504413-35-8.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: N-(6-BroMoiMidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetaMide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(6-BroMoiMidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetaMide(504413-35-8)
• EPA Substance Registry System: N-(6-BroMoiMidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetaMide(504413-35-8)

Safety Data

• Hazardous Substances Data: 504413-35-8(Hazardous Substances Data)

Usage

General Description

N-(6-Bromoimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetamide is a chemical compound with the molecular formula C10H7BrF3N3O. It is a trifluoroacetamide derivative with a substituted imidazo[1,2-a]pyridine ring system. N-(6-BroMoiMidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetaMide is often used in pharmaceutical and medicinal research as a building block for the synthesis of potential drug candidates. Its precise applications and functions can vary widely depending on the specific research goals and experimental conditions. However, its trifluoroacetamide group makes it a versatile and potentially valuable synthetic intermediate for the development of new pharmaceuticals and bioactive compounds.

Upstream product

• 209971-49-3 2,2,2-trifluoro-N-(6-iodoimidazo[1,2-a]pyridin-2-yl)acetamide 
• 937014-94-3 (Z)-2-(5-bromo-2-(tosylimino)pyridin-1(2H)-yl)acetamide 
• 407-25-0 trifluoroacetic anhydride 
• 1005785-49-8 2-[5-bromo-2-{[(4-methylphenyl)sulfonyl]imino}pyridin-1(2H)-yl]acetamide 
• 207801-52-3 N-(5-bromopyridin-2-yl)-4-methylbenzenesulfonamide 
• 1072-97-5 5-bromo-2-pyridylamine 

Downstream Products

• 1162680-84-3 N-(6-bromoimidazo[1,2-a]pyridin-2-yl)acetamide 
• 947249-08-3 N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-2-yl)acetamide 
• 1192831-93-8 N-{6-[3-(methylsulfonyl)phenyl]imidazo[1,2-a]pyridin-2-yl}acetamide 
• 1192832-27-1 6-[3-(methylsulfonyl)phenyl]imidazo[1,2-a]pyridin-2-amine 
• 1192831-91-6 N-(6-{3-[(ethylamino)sulfonyl]phenyl}imidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetamide 
• 1192832-26-0 2,2,2-trifluoro-N-{6-[3-(methylsulfonyl)phenyl]imidazo[1,2-a]pyridin-2-yl}acetamide 
• 947248-52-4 6-bromoimidazole[1,2-a]pyridine-2-amine 

Relevant articles and documents

HETEROARYL COMPOUNDS AS NECROSIS INHIBITORS, COMPOSITION AND METHOD USING THE SAME

The present disclosure provides heteroaryl compounds of Formula (I), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to necrosis. Formula (I) i

FUSED BICYCLIC COMPOUNDS AS INHIBITORS FOR PI3 KINASE

The invention relates to compounds of formula (I) for the regulation of phosphoinositides 3-kinases activity and related diseases.

Inhibitors of PI3 kinase

The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof, that inhibit phosphoinositide 3-kinase; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds.